Wellington Management Group LLP Autolus Therapeutics PLC Transaction History
Wellington Management Group LLP
- $557 Billion
- Q3 2024
A detailed history of Wellington Management Group LLP transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Wellington Management Group LLP holds 24,220,226 shares of AUTL stock, worth $52.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,220,226
Previous 17,889,834
35.39%
Holding current value
$52.8 Million
Previous $62.3 Million
41.22%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AUTL
# of Institutions
104Shares Held
163MCall Options Held
2.8KPut Options Held
13.4K-
Blackstone Inc New York, NY20.5MShares$44.7 Million0.35% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X018.6MShares$40.4 Million83.42% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$33.3 Million2.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$26.9 Million0.67% of portfolio
-
Tfg Asset Management Gp LTD Grand Cayman, E98MShares$17.4 Million10.85% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $198M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...